-transparent.png){kind=logo}
Deconvolution absorption profiles of oral sulpiride formulations were calculated from plasma concentration-time data obtained in an open, 3-period study with a crossover of the 2 oral formulations in 12 healthy volunteers following single intravenous (100 mg) and oral (2 x 50 mg capsules, 200 mg tablets) application of sulpiride. A model based on 2 Weibull-functions, and applied using NONMEM, described the complex absorption profiles more satisfactorily than a first order absorption model or a model based on a single Weibull-function.
Related Publications
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
January 2004,
Biological & pharmaceutical bulletin,
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
September 1986,
Archives internationales de pharmacodynamie et de therapie,
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
September 2002,
Vision research,
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
April 1981,
Food and cosmetics toxicology,
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
January 2020,
Archives of toxicology,
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
January 2007,
Physical review. E, Statistical, nonlinear, and soft matter physics,
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
January 1975,
Therapie,
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
October 2021,
Materials (Basel, Switzerland),
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
January 2014,
Biopolymers,
S Rietbrock, and
P G Merz, and
U Fuhr, and
S Harder, and
J P Marschner, and
D Loew, and
J Biehl
January 1975,
Revista clinica espanola,
